Nachrichten zur Ardelyx Inc. Aktie

Insiderhandel: Vorstand verkauft Aktien von Ardelyx im Wert von 8.745$

Grammer, Elizabeth A. - Vorstand - Tag der Transaktion: 2023-02-21...…

Insiderhandel: Chief Medical Officer verkauft Aktien von Ardelyx im Wert von 9.564$

Williams, Laura A. - Vorstand - Tag der Transaktion: 2023-02-21...…

Ardelyx (ARDX) Gains As Market Dips: What You Should Know

Ardelyx (ARDX) closed the most recent trading day at $2.95, moving +0.34% from the previous trading session....…

Ardelyx (ARDX) Stock Sinks As Market Gains: What You Should Know

Ardelyx (ARDX) closed at $3.02 in the latest trading session, marking a -1.63% move from the prior day....…

Ardelyx (ARDX) Gains As Market Dips: What You Should Know

In the latest trading session, Ardelyx (ARDX) closed at $3.31, marking a +0.91% move from the previous day....…

Ardelyx (ARDX) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Ardelyx (ARDX) closed at $3.07, marking a +1.99% move from the previous day....…

Ardelyx, Inc. Reports Employment Inducement Grants

WALTHAM, Mass., Feb. 2, 2023 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover,…

Ardelyx Up 16%, Rebounding From Thursday Decline

Ardelyx Up 16%, Rebounding From Thursday Decline...…

Thinking about buying stock in Esports Entertainment, Ardelyx, Gaotu Techedu, Hoth Therapeutics, or IQIYI?

NEW YORK, Dec. 29, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GMBL, ARDX, GOTU, HOTH, and IQ. To…

Ardelyx Appeal of Xphozah Denial Granted by FDA

Ardelyx Appeal of Xphozah Denial Granted by FDA...…

Ardelyx rises ~10% as FDA grants appeal for kidney disease drug, refiling plans in H1 2023

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Ardelyx stock rises as FDA grants appeal for new drug application for Xphozah

Ardelyx Inc. ARDX stock is up 5.2% in premarket trades on Thursday after the Waltham, Mass., biopharmaceutical company said the…

Form 8-K ARDELYX, INC. For: Dec 27

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Ardelyx, Inc. Reports Employment Inducement Grants

WALTHAM, Mass., Dec. 23, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover,…

Thinking about buying stock in Core Scientific, DBV Technologies, Gaotu Techedu, New Oriental Education, or Ardelyx?

NEW YORK, Dec. 23, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CORZ, DBVT, GOTU, EDU, and ARDX. To…

Futures Rise On China Growth Hopes

Futures Rise On China Growth Hopes After US stocks…

Ardelyx Shares Lower Premarket on Delay in FDA Xphozah Appeal >ARDX

Ardelyx Shares Lower Premarket on Delay in FDA Xphozah Appeal >ARDX...…

Ardelyx Provides Update on FDA Appeal for XPHOZAH® (tenapanor) for the Control of Serum Phosphorus in Adult Patients with Chronic Kidney Disease on Dialysis

WALTHAM, Mass., Dec. 16, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover,…

Insiderhandel: Chief Development Officer verkauft Aktien von Ardelyx im Wert von 3.796$

Rosenbaum, David P. - Vorstand - Tag der Transaktion: 2022-11-22...…

Ardelyx to Present at the 34th Annual Piper Sandler Healthcare Conference

WALTHAM, Mass., Nov. 22, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover,…

Ardelyx (ARDX) Up 41% After FDA Committee Endorses CKD Drug

The FDAs CRDAC recommends granting marketing approval to Ardelyxs (ARDX) oral pill to control serum phosphorus in adult patients with…

XFRA : 41X: Wiederaufnahme/Resumption

FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING…

Ardelyx shares jump 43% as US FDA advisory panel backs Xphozah

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Ardelyx soars 40% following FDA advisory panel endorsement of kidney disease drug tenapanor

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Ardelyx Skyrockets. Its Kidney Disease Drug Is a Step Closer to FDA Approval.

In a surprise move, a committee of the agency’s outside advisors voted in favor of the proposition that the drug's…

Ardelyx stock rockets on heavy volume after positive FDA panel vote on kidney disease treatment

Shares of Ardelyx Inc. rocketed 75.4% on heavy volume toward a 16-month high in premarket trading Thursday, after an…

Pre-market Movers: ARDX, GRTX, BBWI, PXMD, TNYA .

CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Thursdays pre-market trading (as of 06.40…

Ardelyx Shares Soar Premarket After FDA Panel Back Xphozah >ARDX

Ardelyx Shares Soar Premarket After FDA Panel Back Xphozah >ARDX...…

Ardelyx: FDA Committee Says Benefits of Xphozah Outweigh Risks in Kidney Disease Patients

Ardelyx: FDA Committee Says Benefits of Xphozah Outweigh Risks in Kidney Disease Patients...…

XFRA : 41X: Aussetzung/Suspension

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME …

Ardelyx chronic kidney disease drug tenapanor wins FDA advisory committee backing

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Ardelyx Halted as FDA Panel Takes Another Look at Xphozah >ARDX

Ardelyx Halted as FDA Panel Takes Another Look at Xphozah >ARDX...…

XFRA : INSTRUMENT_SUSPENSION - US0396971071

Instrument ID [7381] (41X - US0396971071) suspended...…

Thinking about buying stock in Canopy Growth Corp, Starbucks, Opiant Pharmaceuticals, Phunware, or Ardelyx?

NEW YORK, Nov. 14, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CGC, SBUX, OPNT, PHUN, and ARDX. To…

National Kidney Foundation and Ardelyx, Inc. Survey Finds Dialysis Patients Struggle to Maintain Serum Phosphorus Levels

Majority of survey respondents call for new treatments to help manage phosphorus levels WALTHAM, Mass. and NEW YORK, Nov. 4,…

Form 8-K ARDELYX, INC. For: Nov 03

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Ardelyx Collaboration Partner, Kyowa Kirin, Announces Submission of New Drug Application for Tenapanor for Hyperphosphatemia in Japan

Ardelyx to receive an aggregate of $35 million in milestone payments and payments associated with the recent amendment of the…

Insiderhandel: Vorstand verkauft Aktien von Ardelyx im Wert von 150.000$

Blanks, Robert - Vorstand - Tag der Transaktion: 2022-10-05...…

dpa-AFX ProFeed